Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Tranexamic-acid | hsa00030 | Pentose phosphate pathway | 5.07E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Tranexamic-acid | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Tranexamic-acid | hsa00500 | Starch and sucrose metabolism | 1.12E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Tranexamic-acid | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Tranexamic-acid | hsa00531 | Glycosaminoglycan degradation | 8.18E-04 | 2 | P15586, P34059 | GNS, GALNS | More | | Tranexamic-acid | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 2.92E-02 | 1 | Q9Y2C2 | UST | More | | Tranexamic-acid | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.52E-03 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Tranexamic-acid | hsa00730 | Thiamine metabolism | 3.83E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Tranexamic-acid | hsa00790 | Folate biosynthesis | 4.05E-02 | 2 | Q92820, P42330 | GGH, AKR1C3 | More | | Tranexamic-acid | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Tranexamic-acid | hsa00970 | Aminoacyl-tRNA biosynthesis | 5.32E-03 | 3 | O95363, P54136, Q15046 | FARS2, RARS1, KARS | More | | Tranexamic-acid | hsa00983 | Drug metabolism - other enzymes | 6.73E-05 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Tranexamic-acid | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | | Tranexamic-acid | hsa03008 | Ribosome biogenesis in eukaryotes | 2.06E-02 | 2 | Q9NYH9, Q9BVP2 | UTP6, GNL3 | More | | Tranexamic-acid | hsa03013 | RNA transport | 4.09E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Tranexamic-acid | hsa03020 | RNA polymerase | 9.80E-05 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | | Tranexamic-acid | hsa03040 | Spliceosome | 1.46E-02 | 4 | P17844, P51991, P61978, P11142 | DDX5, HNRPA3, HNRPK, HSPA8 | More | | Tranexamic-acid | hsa03050 | Proteasome | 3.05E-02 | 1 | P55036 | PSMD4 | More | | Tranexamic-acid | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Tranexamic-acid | hsa04060 | Cytokine-cytokine receptor interaction | 1.74E-04 | 17 | P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P19875, P18510, P01730, Q93038 | IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CXCL2, IL1RN, CD4, TNFRSF25 | More | | Tranexamic-acid | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.36E-04 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Tranexamic-acid | hsa04062 | Chemokine signaling pathway | 5.37E-03 | 9 | P25024, P09341, P19875, P07948, P42338, P19174, P63218, P50151, P43250 | CXCR1, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6 | More | | Tranexamic-acid | hsa04064 | NF-kappa B signaling pathway | 3.72E-09 | 20 | P10415, Q13489, P25963, P51617, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P24522, O75293, P09341, P19875, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, GADD45A, GADD45B, CXCL1, CXCL2, LTB | More | | Tranexamic-acid | hsa04071 | Sphingolipid signaling pathway | 4.33E-05 | 8 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Tranexamic-acid | hsa04080 | Neuroactive ligand-receptor interaction | 1.83E-04 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1 | More | | Tranexamic-acid | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Tranexamic-acid | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Tranexamic-acid | hsa04142 | Lysosome | 1.14E-02 | 3 | P43234, P15586, P34059 | CTSO, GNS, GALNS | More | | Tranexamic-acid | hsa04145 | Phagosome | 1.53E-03 | 9 | Q15080, P14598, Q13509, Q13488, P05164, P78380, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Tranexamic-acid | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | | Tranexamic-acid | hsa04210 | Apoptosis | 1.10E-04 | 14 | Q13315, P04637, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, P18848, Q14643, P63261 | ATM, TP53, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ATF4, ITPR1, ACTG1 | More | | Tranexamic-acid | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Tranexamic-acid | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Tranexamic-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.46E-02 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Tranexamic-acid | hsa04340 | Hedgehog signaling pathway | 1.88E-03 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Tranexamic-acid | hsa04610 | Complement and coagulation cascades | 1.47E-05 | 2 | P00734, P0C0L4 | F2, C4A | More | | Tranexamic-acid | hsa04612 | Antigen processing and presentation | 1.41E-07 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Tranexamic-acid | hsa04613 | Neutrophil extracellular trap formation | 7.28E-05 | 13 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, P14598, Q15080, P20160, P08311, P49913, P21730, P21462 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | | Tranexamic-acid | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Tranexamic-acid | hsa04640 | Hematopoietic cell lineage | 2.66E-04 | 13 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Tranexamic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 5.69E-09 | 12 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P49863 | GZMK | Granzyme K | P01375 | TNF | Tumor necrosis factor | -0.8 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.718 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P06239 | LCK | Tyrosine-protein kinase Lck | -0.709 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.764 | P24158 | PRTN3 | Myeloblastin | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.816 | P51124 | GZMM | Granzyme M | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.743 | P49863 | GZMK | Granzyme K | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.899 | P08311 | CTSG | Cathepsin G | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.92 | P20160 | AZU1 | Azurocidin | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.81 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.703 | P24158 | PRTN3 | Myeloblastin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.729 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P20160 | AZU1 | Azurocidin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.787 | P51124 | GZMM | Granzyme M | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.834 | P24158 | PRTN3 | Myeloblastin | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.732 | P49863 | GZMK | Granzyme K | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.809 | P08311 | CTSG | Cathepsin G | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.812 | P20160 | AZU1 | Azurocidin | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.744 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.803 | P24158 | PRTN3 | Myeloblastin | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.76 | P51124 | GZMM | Granzyme M | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.713 | P49863 | GZMK | Granzyme K | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.96 | P08311 | CTSG | Cathepsin G | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.875 | P20160 | AZU1 | Azurocidin | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.763 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.81 | P49863 | GZMK | Granzyme K | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.775 | P24158 | PRTN3 | Myeloblastin | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.77 | P49863 | GZMK | Granzyme K | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | P20160 | AZU1 | Azurocidin | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.765 | P24158 | PRTN3 | Myeloblastin | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.77 | P49863 | GZMK | Granzyme K | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.891 | P08311 | CTSG | Cathepsin G | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P20160 | AZU1 | Azurocidin | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.765 |
| Tranexamic-acid | hsa04657 | IL-17 signaling pathway | 8.05E-04 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Tranexamic-acid | hsa04658 | Th1 and Th2 cell differentiation | 3.53E-13 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P20160 | AZU1 | Azurocidin | Q04759 | PRKCQ | Protein kinase C theta type | -0.912 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.703 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P20160 | AZU1 | Azurocidin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.787 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.734 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.901 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P06239 | LCK | Tyrosine-protein kinase Lck | -0.709 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P49863 | GZMK | Granzyme K | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.848 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P20160 | AZU1 | Azurocidin | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.724 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P20160 | AZU1 | Azurocidin | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.833 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.73 | P51124 | GZMM | Granzyme M | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.755 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P51124 | GZMM | Granzyme M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.887 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.731 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P20160 | AZU1 | Azurocidin | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.79 | P51124 | GZMM | Granzyme M | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.849 | P49863 | GZMK | Granzyme K | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.704 |
| Tranexamic-acid | hsa04659 | Th17 cell differentiation | 3.02E-10 | 14 | Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49863 | GZMK | Granzyme K | Q04759 | PRKCQ | Protein kinase C theta type | 0.874 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P20160 | AZU1 | Azurocidin | Q04759 | PRKCQ | Protein kinase C theta type | -0.912 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.901 | P49863 | GZMK | Granzyme K | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.756 | P51124 | GZMM | Granzyme M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.783 | P51124 | GZMM | Granzyme M | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P06239 | LCK | Tyrosine-protein kinase Lck | -0.709 | P51124 | GZMM | Granzyme M | P06239 | LCK | Tyrosine-protein kinase Lck | 0.862 | P49863 | GZMK | Granzyme K | P06239 | LCK | Tyrosine-protein kinase Lck | 0.846 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P51124 | GZMM | Granzyme M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.887 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.731 | P49863 | GZMK | Granzyme K | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.882 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P20160 | AZU1 | Azurocidin | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.79 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.909 | P51124 | GZMM | Granzyme M | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.886 | P49863 | GZMK | Granzyme K | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.722 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 | P20160 | AZU1 | Azurocidin | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.741 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.73 | P51124 | GZMM | Granzyme M | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.755 | P49863 | GZMK | Granzyme K | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.918 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P49863 | GZMK | Granzyme K | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.768 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P20160 | AZU1 | Azurocidin | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.833 | P51124 | GZMM | Granzyme M | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.916 | P49863 | GZMK | Granzyme K | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.745 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.734 | P49863 | GZMK | Granzyme K | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.786 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.703 | P51124 | GZMM | Granzyme M | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.824 | P49863 | GZMK | Granzyme K | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.893 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P20160 | AZU1 | Azurocidin | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.787 |
| Tranexamic-acid | hsa04660 | T cell receptor signaling pathway | 8.34E-08 | 18 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Tranexamic-acid | hsa04662 | B cell receptor signaling pathway | 1.07E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Tranexamic-acid | hsa04664 | Fc epsilon RI signaling pathway | 1.29E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Tranexamic-acid | hsa04668 | TNF signaling pathway | 2.36E-03 | 9 | P01375, O00463, Q13489, Q16539, P25963, P09341, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, CXCL1, BCL3, TRAF1, MMP9 | More | | Tranexamic-acid | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Tranexamic-acid | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Tranexamic-acid | hsa04720 | Long-term potentiation | 2.62E-02 | 3 | P18848, P22694, Q14643 | ATF4, PRKACB, ITPR1 | More | | Tranexamic-acid | hsa04724 | Glutamatergic synapse | 2.81E-02 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Tranexamic-acid | hsa04725 | Cholinergic synapse | 3.47E-03 | 6 | P51828, P22694, Q14643, P18848, Q13557, P10415 | ADCY7, PRKACB, ITPR1, ATF4, CAMK2D, BCL2 | More | | Tranexamic-acid | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Tranexamic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.06E-03 | 8 | P14778, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759 | IL1R1, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Tranexamic-acid | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Tranexamic-acid | hsa04912 | GnRH signaling pathway | 2.03E-03 | 5 | P51828, P18848, Q13557, Q14643, P22694 | ADCY7, ATF4, CAMK2D, ITPR1, PRKACB | More | | Tranexamic-acid | hsa04913 | Ovarian steroidogenesis | 4.05E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Tranexamic-acid | hsa04915 | Estrogen signaling pathway | 5.01E-05 | 9 | P14780, P22694, Q99941, P18848, P51828, P07900, P11142, Q14643, P10415 | MMP9, PRKACB, CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8, ITPR1, BCL2 | More | | Tranexamic-acid | hsa04918 | Thyroid hormone synthesis | 1.24E-05 | 6 | P22694, P51828, Q99941, P18848, Q14643, P02768 | PRKACB, ADCY7, CREBL1, ATF4, ITPR1, ALB | More | | Tranexamic-acid | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Tranexamic-acid | hsa04922 | Glucagon signaling pathway | 2.11E-02 | 4 | P22694, P06737, P18848, Q14643 | PRKACB, PYGL, ATF4, ITPR1 | More | | Tranexamic-acid | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Tranexamic-acid | hsa04925 | Aldosterone synthesis and secretion | 4.09E-04 | 6 | Q14643, Q99941, P18848, P51828, Q13557, P22694 | ITPR1, CREBL1, ATF4, ADCY7, CAMK2D, PRKACB | More | | Tranexamic-acid | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Tranexamic-acid | hsa04927 | Cortisol synthesis and secretion | 1.10E-06 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Tranexamic-acid | hsa04928 | Parathyroid hormone synthesis, secretion and action | 7.46E-05 | 7 | Q14643, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | | Tranexamic-acid | hsa04934 | Cushing syndrome | 4.66E-04 | 9 | Q14643, Q99941, P18848, P51828, P22694, P49841, Q9UJU2, Q13557, O00170 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB, GSK3B, LEF1, CAMK2D, AIP | More | | Tranexamic-acid | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Tranexamic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Tranexamic-acid | hsa04970 | Salivary secretion | 4.49E-02 | 4 | P22694, Q14643, P17252, P49913 | PRKACB, ITPR1, PRKCA, CAMP | More | | Tranexamic-acid | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Tranexamic-acid | hsa05016 | Huntington disease | 1.07E-02 | 3 | Q9GZM3, P52435, P55036 | POLR2J2, POLR2J, PSMD4 | More | | Tranexamic-acid | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Tranexamic-acid | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Tranexamic-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P07948 | CXCL1, CXCL2, PLCG1, CXCR1, LYN | More | | Tranexamic-acid | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Tranexamic-acid | hsa05132 | Salmonella infection | 2.98E-02 | 11 | P51617, P25963, P01375, Q9UJU2, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, Q13509 | IRAK1, NFKBIA, TNF, LEF1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, TUBB3 | More | | Tranexamic-acid | hsa05133 | Pertussis | 2.95E-03 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Tranexamic-acid | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Tranexamic-acid | hsa05135 | Yersinia infection | 4.26E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | | Tranexamic-acid | hsa05140 | Leishmaniasis | 1.18E-02 | 7 | P14598, P13765, O60603, P25963, P01375, P51617, Q15080 | NCF1, HLA-DOB, TLR2, NFKBIA, TNF, IRAK1, NCF4 | More | | Tranexamic-acid | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Tranexamic-acid | hsa05144 | Malaria | 9.48E-05 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Tranexamic-acid | hsa05145 | Toxoplasmosis | 3.07E-02 | 7 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2 | More | | Tranexamic-acid | hsa05146 | Amoebiasis | 1.05E-08 | 13 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Tranexamic-acid | hsa05152 | Tuberculosis | 3.11E-03 | 9 | Q13488, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | TCIRG1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Tranexamic-acid | hsa05161 | Hepatitis B | 2.41E-03 | 11 | P17252, P14780, Q99941, P18848, P25963, P01375, P10415, P27348, P51617, O60603, Q14765 | PRKCA, MMP9, CREBL1, ATF4, NFKBIA, TNF, BCL2, YWHAQ, IRAK1, TLR2, STAT4 | More | | Tranexamic-acid | hsa05163 | Human cytomegalovirus infection | 2.64E-02 | 7 | P42338, P63218, P50151, P01106, P14778, Q13651, P30101 | PIK3CB, GNG5, GNG10, MYC, IL1R1, IL10RA, PDIA3 | More | | Tranexamic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.60E-03 | 8 | P42338, P63218, P50151, P09341, P19875, P19174, P07948, P01106 | PIK3CB, GNG5, GNG10, CXCL1, CXCL2, PLCG1, LYN, MYC | More | | Tranexamic-acid | hsa05169 | Epstein-Barr virus infection | 1.82E-03 | 15 | P13765, P01106, Q13547, O00463, Q16539, P42338, P07948, P30101, Q13761, P24522, O75293, O60603, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, MAPK14, PIK3CB, LYN, PDIA3, RUNX3, GADD45A, GADD45B, TLR2, CD3E, CD3G, CD247 | More | | Tranexamic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 1.21E-04 | 21 | P42338, P63218, P50151, P01375, P17252, O00463, P30101, Q14643, P01730, P51617, P25963, O60603, Q13315, O95067, P19174, P07766, P20963, P10415, Q13619, Q93034, Q9Y6Q5 | PIK3CB, GNG5, GNG10, TNF, PRKCA, TRAF5, PDIA3, ITPR1, CD4, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, CD3E, CD247, BCL2, CUL4A, CUL5, AP1M2 | More | | Tranexamic-acid | hsa05202 | Transcriptional misregulation in cancer | 4.42E-08 | 17 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Tranexamic-acid | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | | Tranexamic-acid | hsa05205 | Proteoglycans in cancer | 4.43E-02 | 3 | P63261, P04637, Q06124 | ACTG1, TP53, PTPN11 | More | | Tranexamic-acid | hsa05211 | Renal cell carcinoma | 7.75E-03 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Tranexamic-acid | hsa05212 | Pancreatic cancer | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05213 | Endometrial cancer | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05214 | Glioma | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05216 | Thyroid cancer | 1.14E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05217 | Basal cell carcinoma | 3.28E-03 | 5 | Q13635, P49841, Q9UJU2, P04637, P24522 | PTCH1, GSK3B, LEF1, TP53, GADD45A | More | | Tranexamic-acid | hsa05218 | Melanoma | 1.14E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05220 | Chronic myeloid leukemia | 7.90E-03 | 3 | Q06124, P04637, P24522 | PTPN11, TP53, GADD45A | More | | Tranexamic-acid | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Tranexamic-acid | hsa05223 | Non-small cell lung cancer | 3.19E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05224 | Breast cancer | 4.51E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Tranexamic-acid | hsa05225 | Hepatocellular carcinoma | 3.30E-02 | 3 | P04637, P24522, P63261 | TP53, GADD45A, ACTG1 | More | | Tranexamic-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.09E-06 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Tranexamic-acid | hsa05310 | Asthma | 6.09E-07 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Tranexamic-acid | hsa05321 | Inflammatory bowel disease | 1.48E-11 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Tranexamic-acid | hsa05322 | Systemic lupus erythematosus | 4.90E-03 | 9 | P08246, P08311, P01375, P10747, P13765, Q6FI13, Q16778, P12814, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST2H2BE, ACTN1, SSB | More | | Tranexamic-acid | hsa05323 | Rheumatoid arthritis | 2.72E-02 | 4 | P01375, P13765, P09341, O60603 | TNF, HLA-DOB, CXCL1, TLR2 | More | | Tranexamic-acid | hsa05332 | Graft-versus-host disease | 5.65E-09 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | |